BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200321T100000
DTEND;TZID=America/Toronto:20200321T180000
DTSTAMP:20200203T162942Z
CREATED:20200203T162408Z
LAST-MODIFIED:20200203T162942Z
UID:38416-1584784800-1584813600@globalbiodefense.com
SUMMARY:University of Toronto Global Health & AI Challenge
DESCRIPTION:HOW WILL YOU AND YOUR TEAM USE AI TO SOLVE SOME OF THE MOST COMPLEX GLOBAL HEALTH CHALLENGES\n\n\n\nThe Global Health & AI Challenge\, a partnership between the Dalla Lana School of Public Health and Vector Institute will engage students in critical dialogue and problem-solving scenarios on some of the most complex global health challenges of our time. The top ten threats to global health in 2019 include the climate crisis and air pollution; noncommunicable diseases; an impending influenza pandemic; fragile settings; antimicrobial resistance; high-threat pathogens; inadequate primary health care; vaccine hesitancy; the growing threat of dengue; and the HIV epidemic . All threats to global health exist due to complex\, interrelated economic\, political\, social\, environmental\, and historical factors\, and thus demand creative\, interdisciplinary and intersectoral solutions. Technological innovations and interventions such as AI offer the potential to disrupt these complex threats\, and teams will be tasked with developing solutions that harness the power of AI and machine learning. \n***REGISTRATION DEADLINE IS DECEMBER 8TH\, 2019. SPOTS ARE LIMITED*** \nGlobal Health & AI Challenge Objectives \n\nOffer students local\, accessible experiential and entrepreneurial learning opportunities in global health\nEnhance student learning outcomes around ethical design thinking\, communication\, problem solving\, innovation\, and applying technical skills and AI\nExpand students’ knowledge of the complexity of global health threats and the application of AI-related methodologies and their limitations\nFacilitate student networking and career exploration opportunities\n\nWhat to expect? \n\nJoin a multi-disciplinary team of students to select and tackle a global health challenge.\nApply principles of ethical design thinking to prototype solutions using AI and machine learning.\nAccess an expert team advisor for additional mentorship and guidance.\nCompete to win a team prize of a $500 honorarium\, the opportunity to present your solution to relevant stakeholders (may include investment partners\, organizations or leading experts)\, $100 gift cards to App Store and iTunes\n\nWho can participate? \nThe Global Health & AI Challenge will be open only to current University of Toronto graduate students. Students will be able to sign up individually or in pairs and will then be matched up with students from other programs to ensure teams are multidisciplinary. \nTeams must include at least one student studying in each of the following programs: \n\nDalla Lana School of Public Health (DLSPH)\, including Public Health Sciences & IHPME\nSTEM programs such as Computer Science and Engineering\nRotman School of Management\n\nGraduate students pursuing other programs of study are also encouraged to apply along with a brief statement of interest of no more than 250 words. The optimal number of multidisciplinary teams for this year will be between 6-10\, with 4-6 participants on each team. Students will be able to sign up individually or in pairs and will then be matched up with students from other programs to ensure teams are multidisciplinary. There will be a $25 fee for each student to sign up. \n***REGISTRATION DEADLINE IS DECEMBER 8TH\, 2019. SPOTS ARE LIMITED*** \nTimeline \n\nDecember 8th – deadline for students to apply as individuals or in pairs\nDecember 16th – during this week participating students will be invited to a kickoff introduction event to meet their teammates from other programs.\nJanuary 12th – Teams will submit their initial global health problem identification proposal\nMid January/Early February – Teams will be invited to professional development workshops focused on global health & AI\, design thinking and ethics to apply to their own global health challenge\nFebruary – Each team will be assigned expert team advisor to meet with to provide additional mentorship and guidance.\nMarch 21st – All teams will present their global health challenge and solutions to a panel of judges and stakeholders.\n\nFor more information please contact ghoffice.dlsph@utoronto.ca \n#GHAIChallenge #GlobalHealthDLSPH #VectorInst
URL:https://globalbiodefense.com/event/university-of-toronto-global-health-ai-challenge/
LOCATION:Health Sciences Building\, 155 College Street\, Room 507\, TORONTO\, ON\, M5T 3M7\, Canada
CATEGORIES:Innovation Challenge
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/0299fad3c83db38250c5b87494431a50.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200318T100000
DTEND;TZID=America/New_York:20200318T154500
DTSTAMP:20200210T161026Z
CREATED:20200210T160543Z
LAST-MODIFIED:20200210T161026Z
UID:39238-1584525600-1584546300@globalbiodefense.com
SUMMARY:Next Evolution: Overhauling Key Elements of Biodefense
DESCRIPTION:The Bipartisan Commission on Biodefense will convene a meeting entitled ‘Next Evolution: Overhauling Key Elements of Biodefense‘ on March 18\, 2020 in Washington D.C. and made available by webcast. \nThis meeting aims to inform the assessment of biodefense programs with structural challenges that impede the government’s ability to safeguard the Nation. \nTopics to be discussed at this meeting include the: \n\nSelect Agent Program\nBioWatch Program\nHospital Preparedness Program\n\nSpeakers will share their perspectives\, experiences\, challenges\, and recommended solutions with regard to federal biodetection\, pathogen security\, and hospital preparedness programs. \nRegistration is required and attendance is free. \nWednesday\, March 18\, 2020 \n10:00 AM – 3:45 PM \nHudson Institute \n1201 Pennsylvania Avenue\, NW\, 4th floor \nWashington\, DC 20004 \nSee map \n  \n 
URL:https://globalbiodefense.com/event/next-evolution-overhauling-key-elements-of-biodefense/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200316
DTEND;VALUE=DATE:20200318
DTSTAMP:20200223T181226Z
CREATED:20200223T173102Z
LAST-MODIFIED:20200223T181226Z
UID:40151-1584316800-1584489599@globalbiodefense.com
SUMMARY:IABS-CEPI Vaccine Technology Platforms Meeting
DESCRIPTION:A cross-learning symposium on vaccine licensure based on technology platforms\, the IABS-CEPI-ZAPI Technology Platforms Meeting\, will take place 16-17 March 2020 in Brussels\, Belgium. \nThe scientific committee for this workshop is co-Chaired by: \n\nDaniel Brasseur\, former CHMP-PDCO-VWP chair at EMA; CEPI consultant\nMurray Lumpkin\, former Deputy Director\, FDA; Bill & Melinda Gates Foundation\n\nHighlighted topics of interest on the agenda include: \n\nWHO regulatory preparedness activities to facilitate access to emergency vaccines\nHuman influenza vaccine successes and failures\nLessons for emergency preparedness leaned from Ebola vaccine development and licensure\nRegulatory approach to vaccine tech platforms: FDA perspective\, EU approach\, AVAREF\, Asian regulators\nAdvanced human vaccines in the pipeline (viral vectors\, VSV-Measles-ChAd…) and RNA\, DNA technologies\nTo what extent can clinical trials be pre-arranged?\nDetermining what is platform generic vs. platform specific in manufacturing and quality control\nChallenges to prove vaccine efficacy for outbreak vaccines and mitigating risk\nStreamlining regulatory acceptance from ‘tried and true’ vaccine platforms\n\nIn addition\, CEPI will review its current portfolio and examples of vaccine candidates based on technology platforms. \nMembers of the Scientific Committee include: \n\nDr. Barney Graham\, NIH\, Deputy Director and Chief\, Viral Pathogenesis Laboratory\nDr. Mélanie Saville\, Director\, Vaccine Development\, CEPI\nProf. Dr. Johan Neyts\, Rega Institute Louvain\, Belgium\, specialist of DNA vaccine PLLAV\nDr. Marion Gruber\, FDA\, Director\, Office of Vaccine Research and Review – CBER\nDr. Ivo Classen\, EMA\, Head of Veterinary Medicines Division\nDr. Marco Cavaleri\, EMA\, Head of Anti-infectives and Vaccines\nProf Dr. Jeffery Almond\, Oxford University; Chairman of the Board\, Osivax\nDr. Jean-Christophe Audonnet\, Senior Director\, Vaccines R&D; ZAPI Project Coordinator;\nBoehringer Ingelheim Animal Health\nDr. Emmanuel Hanon\, Senior Vice President\, Head of R&D\, GSK Vaccines\nDr Ajoy Chakrabarti\, Bill & Melinda Gates Foundation Vaccine Development\nDr Steve Black\, The Brighton Collaboration\, Task Force for Global Health\n\nRegister now for the IABS-CEPI Technology Platforms Meeting
URL:https://globalbiodefense.com/event/iabs-cepi-vaccine-technology-platforms-meeting/
CATEGORIES:Conference,Industry Day
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200312T130000
DTEND;TZID=America/New_York:20200312T143000
DTSTAMP:20200220T011222Z
CREATED:20200220T010949Z
LAST-MODIFIED:20200220T011222Z
UID:39863-1584018000-1584023400@globalbiodefense.com
SUMMARY:Center for the Study of WMD Spotlight Seminar: Coronavirus and Biosecurity
DESCRIPTION:The outbreak of the deadly coronavirus is the latest global health crisis to capture the headlines and the fears of the world. With daily updates from health officials\, there is both a surfeit of information and plenty of misinformation about the disease\, its spread\, and its origin. \nPlease join us at the Center for the Study of Weapons of Mass Destruction March Spotlight Seminar on “Coronavirus and Biosecurity.” The panel will feature experts in the fields of bioterrorism\, biosurveillance\, and infectious disease who can provide timely context for the outbreak. Panelists will assess the response to the public health emergency by the United States and China and discuss what this novel coronavirus may teach us for future natural and intentional biological events. \nIf you have any questions about the event\, please contact the CSWMD Admin staff at CSWMD-Admin@ndu.edu or call 202-433-6382. \nBiographies:\nDr. Gigi Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Johns Hopkins Bloomberg School of Public Health. She is an immunologist by training. Dr. Gronvall’s work at the Center for Health Security addresses the role of scientists in health security—how they can contribute to an effective technical response against a biological weapon or a natural epidemic. She is particularly interested in developing policies that will boost the safety and security of biological science activities while allowing beneficial research to flourish. Dr. Gronvall is the author of the books Synthetic Biology: Safety\, Security\, and Promise and Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. \nDr. Noreen Hynes has more than 40 years of medical and public health experience in both international and domestic settings. She is a physician trained in internal medicine\, infectious diseases\, tropical medicine\, and epidemiology. Prior to her medical education\, Dr. Hynes served as a Peace Corps Volunteer in Tunisia\, followed by serving as a Foreign Service Officer in Mali and Cote d’Ivoire\, and then received a master of public health degree from Johns Hopkins University. After earning a medical degree from the Uniformed Services University of the Health Sciences in Bethesda\, MD\, Dr. Hynes completed a residency in internal medicine and a fellowship in infectious diseases at the Massachusetts General Hospital/Harvard Medical School. As a Commissioned Officer in the U.S. Public Health Service\, Dr. Hynes’ duty stations included Atlanta (Epidemic Intelligence Service)\, Colorado\, Arkansas\, Baltimore\, and Washington D.C. Following the events of late 2001\, she served as senior advisor to the Vice President of the United States for Medicine and Public Health (Homeland Security). Prior to retirement from government service in 2007\, Dr. Hynes was the deputy assistant secretary for Public Health Emergency Preparedness and the director of the Office of Public Health Emergency Medical Countermeasures (now the Biomedical Advanced Research and Development Authority – BARDA) at the US Department of Health and Human Services. Since 1997\, Dr. Hynes has been a part-time faculty member at the Johns Hopkins University Schools of Medicine and Public Health. She directs the Geographic Medicine Center of the Division of Infectious Diseases and serves as the associate medical director of the Biocontainment Unit of the Johns Hopkins Hospital — a unit focused on the care of patients with high consequence pathogens\, such as Ebola. At the Bloomberg School of Public Health\, Dr. Hynes co-directs the infectious diseases concentration in the master of public health program and co-teaches a course focused on the science\, public health and policy aspects of chemical and biological weapons. Her research focuses on vaccine-preventable diseases\, tropical diseases\, zoonotic infections\, and high consequence pathogens. \nDr. Rohit Chitale joined DARPA as a program manager in 2019. He is an infectious disease epidemiologist with more than 20 years of experience helping national and international organizations establish and lead programs related to infectious disease prevention and eradication\, with specific expertise in the design and implementation of disease surveillance systems and the development of new disease control tools. Before coming to DARPA\, Dr. Chitale co-established the Global Disease Detection Operations Center at the U.S. Centers for Disease Control and Prevention (CDC)\, the first event-based all-hazards surveillance unit at the CDC. He also served as the CDC Country Director in the Republic of South Sudan. In a prior role at the U.S. Department of Defense (DoD)\, he established and led the Division of Integrated Biosurveillance within the Armed Forces Health Surveillance Center to address capability gaps in DoD biosurveillance and global health security operations. In that role\, he led efforts to integrate syndromic\, case-based\, and event-based disease surveillance systems across civilian\, military\, and veteran populations to decrease the time to disease detection\, diagnosis\, and treatment. While at DoD\, he helped write the Global Health Security Agenda legislation. Previously\, at the Johns Hopkins Bloomberg School of Public Health\, Dr. Chitale co-created The MENTOR Initiative — a public-private partnership designed to test and evaluate (pre-clinical\, Phase I\, II\, and III trials) new vector-borne disease control technologies.
URL:https://globalbiodefense.com/event/center-for-the-study-of-wmd-spotlight-seminar-coronavirus-and-biosecurity/
LOCATION:National Defense University\, 300 5th Avenue SW\, Washington\, DC\, 20319\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200310T133000
DTEND;TZID=America/New_York:20200310T143000
DTSTAMP:20240623T230635Z
CREATED:20200305T230620Z
LAST-MODIFIED:20240623T230635Z
UID:40918-1583847000-1583850600@globalbiodefense.com
SUMMARY:Journalists Covering COVID-19: What Do You Need to Know
DESCRIPTION:Association of Health Care Journalists (AHCJ) members are invited to a special webcast event “Covering COVID-19: What Do You Need to Know?” on 10 March 2020. \nThe COVID-19 outbreak story is evolving quickly and there are many unknowns about the epidemic\, including how contagious the virus is\, its mortality rate and whether there is undetected spread occurring outside of China. Providing accurate information to the public is more important than ever in this moment of uncertainty. Hear a panel of infectious disease experts and a journalist explain what is known\, what to watch out for\, where to find trusted resources and how to combat misinformation and confusion. \n\nMaryn McKenna\, independent journalist\, author; Senior Fellow of the Center for the Study of Human Health at Emory University\nMichael Osterholm\, Ph.D.\, M.P.A.\, director\, Center for Infectious Disease Research and Policy\nSaskia Popescu\, senior infection preventionist\, ELBI Fellow and managing editor; HonorHealth\, Johns Hopkins Center for Health Security\, Pandora Report\nAngie Rasmussen\, Ph.D.\, Columbia University Mailman School of Public Health\, Associate Research Scientist\nModerator: Bara Vaida\, AHCJ core topic leader/infectious diseases\n\nSaskia Popescu is an experienced infectious disease epidemiologist and infection preventionist with a strong background in project management\, translation of complex issues into frontline applications\, and enhancing healthcare biopreparedness. She is passionate about healthcare biopreparedness\, antimicrobial resistance\, and driving change across sectors in global health security. \nAngie Rasmussen\, Ph.D.\, is an associate research scientist at Columbia University’s Mailman School of Public Health. She is a virologist studying host responses to infection by combining classical virology with modern systems biology approaches. Her research objectives are to identify host response signatures predictive of infection severity or disease outcome and host pathways to target drug development or repurposing. She is particularly interested in viruses that are highly pathogenic\, newly emergent or likely to emerge because of climate change\, land development\, or ecological disruption. \nMaryn McKenna is a journalist and book author and teaches health and science writing and storytelling\, and media literacy. She has reported from epidemics and disasters\, and farms and food production sites\, on most of the world’s continents\, including a field hospital in New Orleans during Hurricane Katrina\, to Midwestern farms devastated by the 2015 epidemic of avian flu. She writes for The New York Times Magazine\, The New Republic\, WIRED\, Smithsonian\, The Atlantic\, NPR\, and numerous other magazines and sites. She is the author of the 2017 bestseller Big Chicken: The Incredible Story of How Antibiotics Created Modern Agriculture and Changed the Way the World Eats (National Geographic Books\, Sept. 2017)\, which received the 2018 Science in Society Award\, making her a two-time winner of that prize. \nPlease visit the AHCJ’s Covering COVID-19: What Do You Need to Know event website for more information.
URL:https://globalbiodefense.com/event/journalists-covering-covid-19-what-do-you-need-to-know/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200303T103000
DTEND;TZID=Europe/London:20200305T132000
DTSTAMP:20200203T163102Z
CREATED:20200203T162235Z
LAST-MODIFIED:20200203T163102Z
UID:38411-1583231400-1583414400@globalbiodefense.com
SUMMARY:National Museum of Scotland Outbreak Lab Workshop
DESCRIPTION:In this hands‐on\, experimental workshop\, pupils will use real laboratory techniques from Easter Bush Science Outreach Centre to track the outbreak of an infectious\, parasitic disease.  \nSuitable for: S1–3 \nCost: Free of charge   \nNo of pupils: 24 per session max \nTimings: 10:30–13:00 or 11:00–13:30  \n(60 minute workshop\, 60 minute exhibition & gallery visit) \nDates: Tue 3–Thu 5 Mar 2020  \nIn this hands‐on\, experimental workshop\, pupils will use real laboratory techniques from Easter Bush Science Outreach Centre to track the outbreak of an infectious\, parasitic disease.  \n They will use micropipettes and other lab equipment to perform a mock diagnostic test\, supported by scientists from The Roslin Institute and Edinburgh Infectious Diseases. Pupils will work as a group to interpret their results and agree on a recommended course of action.  \n The session l also covers some of the science behind disease diagnosis and how parasitic diseases can spread between animals and humans\, and gives pupils the opportunity to meet and interact with professional scientists who are working on infectious diseases.  \n Class A  \n10:30–11:30 – Workshop  \n11:30–12:00 – Visit Parasites exhibition  \n12:00–12:30 – Visit Science & Technology galleries  \n12:30–13:00 – Lunch (space set aside in lunchroom for packed lunches) \n Class B \n11:00–11:30 – Visit Parasites exhibition \n11:30–12:00 – Visit Science & Technology galleries  \n12:00–12:30 – Lunch (space set aside in lunchroom for packed lunches) \n12:30–13:30 – Workshop  \nThis event is run in partnership with the University of Edinburgh’s Roslin Institute\, Easter Bush Science Outreach Centre and Edinburgh Infectious Diseases. \nClasses must be accompanied by a teacher.  \nBy reserving 1 timeslot\, you can bring up to 24 pupils. If you are bringing less than 24\, please let us know on the booking form and we may combine with a small class from a different school.  \n\nTravel Subsidy \nThe University of Edinburgh is able to provide some financial support towards travel expenses for schools attending this workshop. This is specifically targeted at state schools in deprived areas\, where more than 45% of pupils are in the lowest 20% SIMD category. The support would be up to a max of £200 per school. This is available on a first come\, first served basis. Please enquire upon booking for further information.
URL:https://globalbiodefense.com/event/outbreak-lab-workshop/
LOCATION:National Museum of Scotland\, Chambers Street\, Edinburgh\, Scotland\, EH1 1JF\, United Kingdom
CATEGORIES:Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/1687fc97b850305839f2659d50c82977-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200303
DTEND;VALUE=DATE:20200306
DTSTAMP:20191227T222008Z
CREATED:20191115T214342Z
LAST-MODIFIED:20191227T222008Z
UID:36020-1583193600-1583452799@globalbiodefense.com
SUMMARY:Mitigating the Impact of Blast-related Burn Injuries: From Prolonged Field Care to Rehabilitation and Resilience
DESCRIPTION:The 9th DoD State-of-the-Science Meeting on Blast Injury Research will be held March 3-5\, 2020 in Arlington\, Virginia. \nThe meeting will address epidemiology and outcomes of blast-related burn injuries; prevention and acute management of blast-related burn injuries; prolonged field care and chronic care; and transforming research. \nThis meeting is sponsored by the DoD Blast Injury Research Coordinating Office\, U.S. Army Medical Research and Development Command\, on behalf of the DoD Executive Agent for Medical Research for Prevention\, Mitigation\, and Treatment of Blast Injuries. \nThe event is presented by the RAND National Security Research Division (NSRD)\, which conducts research and analysis for all national security sponsors other than the U.S. Air Force and the Army. The division includes the National Defense Research Institute\, a federally funded research and development center whose sponsors include the Office of the Secretary of Defense\, the Joint Staff\, the Unified Combatant Commands\, the defense agencies\, and the Department of the Navy. NSRD also conducts research for the U.S. intelligence community and the ministries of defense of U.S. allies and partners. \nThis will be a working meeting. Over 100 subject matter experts from the DoD\, other Federal agencies\, academia\, industry\, and the international community are expected to participate. \nAttendance is free\, first come-first serve\, and capped at 150. There are no continuing education credits\, and participants are responsible for their own travel\, lodging\, and expenses. \nEDITOR’S UPDATE: Registration for the Ninth State-of-the-Science Meeting is now full. If you would like to be added to the waitlist\, contact the event organizers here.
URL:https://globalbiodefense.com/event/mitigating-the-impact-of-blast-related-burn-injuries-from-prolonged-field-care-to-rehabilitation-and-resilience/
LOCATION:RAND’s Pentagon City Office\, 4th Floor\, 1200 South Hayes Street\, Arlington\, VA\, 22202-5050\, United States
CATEGORIES:Conference,Government Hosted
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T140000
DTEND;TZID=America/New_York:20200302T150000
DTSTAMP:20200126T224530Z
CREATED:20200126T224350Z
LAST-MODIFIED:20200126T224530Z
UID:37784-1583157600-1583161200@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-5/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200302T113000
DTEND;TZID=America/New_York:20200302T120000
DTSTAMP:20200301T230419Z
CREATED:20200301T230209Z
LAST-MODIFIED:20200301T230419Z
UID:40566-1583148600-1583150400@globalbiodefense.com
SUMMARY:COVID-19 Live Webcast with Johns Hopkins Experts
DESCRIPTION:With COVID-19 now spreading via community transmission in the U.S. and the World Health Organization raising its risk assessment to “very high\,” the Johns Hopkins Bloomberg School of Public Health will host a 30-minute webcast featuring some of the best minds addressing this global health concern. \nYou’ll hear from Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins Center for Health Security and Lauren Sauer of the Johns Hopkins Office of Critical Event Preparedness and Response. The conversation will be moderated by Dr. Joshua Sharfstein\, Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former secretary of Maryland’s Department of Health. \nThey’ll discuss the findings of the Global Health Security Index referenced by President Trump last week\, what you need to know about community transmission and how to protect yourself from misinformation. They will also answer viewer questions submitted before and during the broadcast. \nSpeakers\n\nJennifer Nuzzo\, DrPH\, SM\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nTara Kirk Sell\, PhD\, MA\nSenior Scholar\, Johns Hopkins Center for Health Security\nJohns Hopkins Bloomberg School of Public Health\nLauren M. Sauer\, MS\nDirector of Operations\, Johns Hopkins Office of Critical Event Preparedness and Response\nJohns Hopkins University School of Medicine\nJosh Sharfstein\, MD\nModerator\nVice Dean for Public Health Practice and Community Engagement\nJohns Hopkins Bloomberg School of Public Health\n\nA recording will be made available via on The Hub’s dedicated coronavirus page at https://hub.jhu.edu/novel-coronavirus-information/ and across Bloomberg School channels. \nThe Johns Hopkins Bloomberg School of Public Health will host additional webcasts as the coronavirus outbreak continues. Follow us on Twitter\, Facebook\, LinkedIn\, and Instagram to be notified about future broadcasts. \nThe Bloomberg School is also launching a daily “Public Health On Call” podcast with an immediate focus on the coronavirus outbreak. Subscribe via YouTube or Libsyn.
URL:https://globalbiodefense.com/event/covid-19-live-webcast-with-johns-hopkins-experts/
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200229
DTEND;VALUE=DATE:20200305
DTSTAMP:20200210T165602Z
CREATED:20200210T162700Z
LAST-MODIFIED:20200210T165602Z
UID:39241-1582934400-1583366399@globalbiodefense.com
SUMMARY:16th CDC International Symposium on Biosafety
DESCRIPTION:The 16th CDC International Symposium on Biosafety – Laboratory Safety and Security for Clinical\, Public Health\, Research and Animal Care will be held 29 February – 4 March\, 2020 in Atlanta\, Georgia. \nStakeholders will learn about the soon-to-be-released 6th edition of the BMBL\, gaps in clinical and research biosafety\, risk management tools for animal facilities\, virtual reality training\, poliovirus containment\, and more. \nHighlighted sessions include: \n\nExperiences Coordinating Laboratory Policies and Procedures at CDC \nSteve Monroe\, PhD\, Centers for Disease Control and Prevention\nLaboratory Emergency Response Plans: A Team Approach\nPatrick Stockton\, MS\, RBP\, University of Georgia (Biosafety)\, Steve Harris\, University of Georgia (Emergency Preparedness)\, Captain Adam Fouche\, University of Georgia (Police)\, and Roger L. Evans\, Athens Clark County (Fire)\nLessons Learned in Risk Assessment for the Laboratory and Beyond\nRyan Ritterson\, PhD\, Gryphon Scientific\nIssues in Operation and Decontamination in Animal Research Facilities\nJason Villano\, DVM\, MSc\, MS\, DACLAM\, Johns Hopkins University \nDecontamination in the Clinical Laboratory: A Unique Environment\nSheldon Campbell\, MD\, PhD\, FCAP\, Yale School of Medicine\nUsing Risk Assessment to Identify\, Evaluate and Prioritize Facility Repairs\nJohn R. Henneman\, M.S.\, RBP/ABSA\, Biosecurity Research Institute and Miguel A. Grimaldo\, M. Eng\, University of Texas Medical Branch\n\nPlease visit the Eagleson Institute’s CDC Biosafety Symposium website for more information and to register.
URL:https://globalbiodefense.com/event/16th-cdc-international-symposium-on-biosafety/
LOCATION:Westin Perimeter North Hotel\, 7 Concourse Pkwy NE\, Atlanta\, GA\, 30328\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200228T140000
DTEND;TZID=Europe/London:20200228T170000
DTSTAMP:20200203T163127Z
CREATED:20200203T162156Z
LAST-MODIFIED:20200203T163127Z
UID:38406-1582898400-1582909200@globalbiodefense.com
SUMMARY:Faculty of Natural Sciences Research Seminar: Infectious Diseases
DESCRIPTION:Join the next FoNS Research Seminar and learn the cutting-edge research on infectious diseases taking place across the Faculty\n\n\n\nThe Faculty regularly organises events that showcase its strong research areas in order to stimulate new collaborations and discussions around a topic. The next one will be on the topic of “Infectious Diseases”. Our highlighted speakers are: \n\nProf. Ed Tate\, Professor in Chemical Biology\, Department of Chemistry\n\n\nDr Anna Barnard\, Sir Henry Dale Fellow\, Department of Chemistry\n\n\nDr Abigail Clements\, Lecturer\, Department of Life Sciences\n\n\nDr Gerald Larrouy-Maumus\, Senior Lecturer\, Department of Life Sciences\n\n\nDr Oliver Ratmann\, Lecturer in Statistics\, Department of Mathematics\n\nPhD students and postdocs will also participate at this event and their names will be announced very soon. Note there will be a drinks & canapes reception afterwards! \nFor further details about this event\, please see the event’s website.
URL:https://globalbiodefense.com/event/faculty-of-natural-sciences-research-seminar-infectious-diseases/
LOCATION:Imperial College London\, Sir Alexander Fleming Building G34 LT\, Exhibition Road\, London\, SW7 2AZ\, United Kingdom
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/89a4e54954d51d64e4de06a176f38c9a.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200228
DTEND;VALUE=DATE:20200229
DTSTAMP:20200211T234244Z
CREATED:20200211T234042Z
LAST-MODIFIED:20200211T234244Z
UID:39305-1582848000-1582934399@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68\nSupports the development of inactivated Enterovirus D68 vaccines\, preferably using adjuvants that minimize regulatory concerns and expedite vaccine development into a Phase I clinical trial. \nDue Date: February 28\, 2020\, by 3 p.m. Eastern Time \n  \nLearn more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-advanced-development-of-vaccine-candidates-for-acute-flaccid-myelitis-afm-associated-with-enterovirus-d68/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200227T140000
DTEND;TZID=America/New_York:20200227T160000
DTSTAMP:20200220T230510Z
CREATED:20200220T225626Z
LAST-MODIFIED:20200220T230510Z
UID:40056-1582812000-1582819200@globalbiodefense.com
SUMMARY:Coronavirus Disease 2019: The U.S. and International Response
DESCRIPTION:The House Foreign Affairs Subcommittee on Asia\, the Pacific\, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. \nWitnesses will include U.S. government officials who have led the response to the virus. \nDate: Thursday\, February 27\, 2020 \nTime: 2:00 p.m. EST \nSubject: Coronavirus Disease 2019: The U.S. and International Response \nWitnesses: \n\nMr. Ian Brownlee\nPrincipal Deputy Assistant Secretary\, Bureau of Consular Affairs\, U.S. Department of State \nMr. Jonathan Fritz\nDeputy Assistant Secretary\, Bureau of East Asian and Pacific Affairs\, U.S. Department of State \nWilliam A. Walters\, Ph.D.\nExecutive Director and Managing Director for Operational Medicine\, Bureau of Medical Services\, U.S. Department of State \nRobert Redfield\, Ph.D.\nDirector\, U.S. Centers for Disease Control and Prevention
URL:https://globalbiodefense.com/event/coronavirus-disease-2019-the-u-s-and-international-response/
LOCATION:Rayburn House Office Building\, Washington\, DC\, United States
CATEGORIES:Conference,Government Hosted,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200226
DTEND;VALUE=DATE:20200227
DTSTAMP:20200206T192309Z
CREATED:20200206T191959Z
LAST-MODIFIED:20200206T192309Z
UID:38920-1582675200-1582761599@globalbiodefense.com
SUMMARY:Emerging Bioethical Issues in Biomedical Research: A Workshop
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will conduct a one day workshop on Feb 26\, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. \nThe workshop will identify a range of current and emerging bioethical issues – both in basic and clinical research – and explore a broad-range of stakeholder perspectives. Input will be sought from a variety of perspectives which may include patients/participants/individuals\, bioethicists\, academic and industry researchers\, clinicians\, and government representatives. The workshop will describe the state of the emerging science and potential pressing\, recurring\, emerging\, and/or anticipated future bioethical issues in biomedical research and society that fall within the scope of the research and policy activities of the NIH. Potential topics may include: \n\nUse of digital technologies\, artificial intelligence\, and machine learning in biomedical research and clinical care;\nEmerging ethical challenges for sharing data from human research participants and use of human biospecimens;\nHealth equity and health disparities in research\, including:\n\nRecognizing and addressing barriers to participation in research and clinical care across diverse populations and groups\nUnderstanding the impact of cultural and social context on health and disease\nEquitable distribution of the benefits and burdens of research;\n\n\nInnovative study designs\, including crowdsourcing of research and citizen science;\nNovel approaches for enhancing bioethics infrastructure and training;\nNew means for assessing and enhancing scientific workforce diversity; and/or\nInnovative solutions for enhancing research oversight infrastructure.\n\nGiven the broad scope of bioethical issues in research and the difficulty in addressing all possible issues in a single workshop\, the following topics fall outside the scope of this workshop as they are being addressed in multiple other venues: gene editing\, gene drives\, human-animal chimera research\, human fetal tissue research\, neuroethics\, and animal care and welfare. The planning committee will develop the agenda for the workshop\, select and invite speakers and discussants\, and moderate or identify moderators for the discussions. A workshop proceedings will be prepared by a designated rapporteur based on the information gathered and discussions held during the workshop in accordance with National Academies institutional policies and procedures. \nNote: Registration for in-person attendance is full. You may register for the webcast HERE. If you are interested in signing up for the in-person waitlist\, please register HERE and we will contact you if a spot becomes available.
URL:https://globalbiodefense.com/event/emerging-bioethical-issues-in-biomedical-research-a-workshop/
CATEGORIES:Webinar-Webcast,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200225
DTEND;VALUE=DATE:20200227
DTSTAMP:20191227T194207Z
CREATED:20191227T194138Z
LAST-MODIFIED:20191227T194207Z
UID:36013-1582588800-1582761599@globalbiodefense.com
SUMMARY:Developing MCMs to Treat Acute and Chronic Effects of Ocular Chemical Toxicity
DESCRIPTION:A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26\, 2020 at the NIAID Conference Center in Rockville\, Md. \nThis meeting\, sponsored by the NIH Chemical Countermeasures Research Program (CCRP) and organized in collaboration with the National Eye Institute (HHS/NIH/NEI) and U.S. Army Medical Research Institute for Chemical Defense (DoD/USAMRICD)\, will bring together subject matter experts from the civilian and military research communities to discuss the current state of the field\, including potential therapeutic approaches and available models. \n\nDevelopment of MCMs that mitigate acute and chronic corneal manifestations in response to ocular toxicants relies on the development of well-characterized experimental models with defined pathophysiology that allow for effective bridging to humans. Such models are also essential to demonstrate therapeutic efficacy. \nAttendees of the workshop will contribute to our understanding of pathologies and models available for studying toxic ocular injuries and their utility in the research and development of therapeutics. Most importantly\, the workshop will address current knowledge gaps to identify possible refinements or new directions to advance MCM development. \n\nHighlighted session topics include: \n\n\nAcute and Chronic Wound Healing Responses to Corneal Toxicity\nMechanistic Basis of Corneal Pathophysiologies\nTherapeutically Accessible Models of Corneal Toxic Injury\nTherapeutic Approaches to Mitigate Corneal Pathophysiologies\nCurrent Research & Development Perspectives and Resources for Researchers\nMeeting Wrap Up \n\n\nPlease visit the NIAID event website for more information. Register by January 31\, 2020. \nEdited by S. Lizotte
URL:https://globalbiodefense.com/event/developing-mcms-to-treat-acute-and-chronic-effects-of-ocular-chemical-toxicity/
CATEGORIES:Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200224T140000
DTEND;TZID=America/New_York:20200224T150000
DTSTAMP:20200126T214159Z
CREATED:20200126T193833Z
LAST-MODIFIED:20200126T214159Z
UID:37781-1582552800-1582556400@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-4/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200220
DTEND;VALUE=DATE:20200221
DTSTAMP:20200212T001500Z
CREATED:20200212T001251Z
LAST-MODIFIED:20200212T001500Z
UID:39322-1582156800-1582243199@globalbiodefense.com
SUMMARY:DARPA BTO BAA Deadline: Personalized Protective Biosystems
DESCRIPTION:The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator\, provide operational flexibility\, extend mission duration\, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing a second layer of protection\, at the tissue barrier\, with bio-molecular\, commensal organisms\, or other technologies that protect the skin\, eyes\, and airway from CB threats. PPB will improve mission execution by solving the current protective equipment limitations including threat-specific vulnerabilities\, thermal/logistical burdens\, exposure risks during equipment removal/decontamination\, and on-demand availability during unexpected threat situations. \nA Proposer’s Day was held on 4 Dec 2019 for potential performers. Attendance at the event is not a prerequisite to submit a response to the DARPA Personalized Protective Biosystem Broad Agency Announcement (BAA). The full proposal deadline for this BAA is 20 February 2020. \nLearn more about this opportunity in Funding News. \n  \n## \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/darpa-bto-baa-deadline-personalized-protective-biosystems/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20200219T170000
DTEND;TZID=America/Toronto:20200219T191500
DTSTAMP:20200203T162738Z
CREATED:20200203T162443Z
LAST-MODIFIED:20200203T162738Z
UID:38421-1582131600-1582139700@globalbiodefense.com
SUMMARY:2019-nCoV Update for  Health Care Providers
DESCRIPTION:Target Audience: Health care providers (including primary care physicians & nursing professionals)\n\n\n\nKey Note Speakers: \n\nDr. Gerald Evans Chair of the Division of Infectious Diseases\, Professor of Medicine\, Queens University; Attending Staff\, Kingston Health Sciences Centre\nDr. Piotr Oglaza Medical Officer of Health & CEO\, Hastings Prince Edward Public Health\nYvonne DeWit\, Epidemiologist\, Hastings Prince Edward Public Health\nMorgan Harnest\, Infection Control Lead\, PHN\, Hastings Prince Edward Public Health\n\nTopics: \n\nThe 2019 novel coronavirus\nEpidemiology\nPublic Health Response\nPersonal Protective Equipment\nWhat’s New\n\nRegistration is required. A light dinner will be provided. Please let us know if you have any dietary restrictions. \nPlease register by February 17th\, 2020.
URL:https://globalbiodefense.com/event/2019-ncov-update-for-health-care-providers/
LOCATION:Hastings Prince Edward Public Health\, 179 North Park Street\, Belleville\, ON\, K8P 4P1\, Canada
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/8f447dac25fd3022c25eafa4210f5a82.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200219T150000
DTEND;TZID=America/New_York:20200219T160000
DTSTAMP:20200208T165510Z
CREATED:20200208T165105Z
LAST-MODIFIED:20200208T165510Z
UID:39162-1582124400-1582128000@globalbiodefense.com
SUMMARY:Public Health Emergency Preparedness (PHEP) Monthly Call
DESCRIPTION:PHEP Recipient Monthly Conference Call Scheduled for February 19 \nCDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday\, February 19. Participant information is provided below. \n  \nConference Call Information \nBridge Line: (888) 566-1873 \nParticipant Code: 3358383 \n  \nThe Public Health Emergency Preparedness (PHEP) cooperative agreement is a critical source of funding for state\, local\, and territorial public health departments. Since 2002\, the PHEP cooperative agreement has provided assistance to public health departments across the nation. This helps health departments build and strengthen their abilities to effectively respond to a range of public health threats\, including infectious diseases\, natural disasters\, and biological\, chemical\, nuclear\, and radiological events. Preparedness activities funded by the PHEP cooperative agreement specifically targeted the development of emergency-ready public health departments that are flexible and adaptable.
URL:https://globalbiodefense.com/event/public-health-emergency-preparedness-phep-monthly-call/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200214
DTEND;VALUE=DATE:20200215
DTSTAMP:20200212T001055Z
CREATED:20200204T000815Z
LAST-MODIFIED:20200212T001055Z
UID:39319-1581638400-1581724799@globalbiodefense.com
SUMMARY:Deadline: CEPI Call for Proposals - Vaccines Against Novel Coronavirus
DESCRIPTION:CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. \nThe call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations\, for-profit companies\, international organisations and foundations\, joint R&D ventures\, government research organisations\, and academic institutions ideally having a geographical footprint internationally. \nLearn more in funding news. \nThe deadline for applications is Friday 14 Feb (2020)\, 15:00 CET. \n  \n## \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-cepi-call-for-proposals-vaccines-against-novel-coronavirus/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200212T090000
DTEND;TZID=America/New_York:20200212T113000
DTSTAMP:20200206T212739Z
CREATED:20200204T172100Z
LAST-MODIFIED:20200206T212739Z
UID:38776-1581498000-1581507000@globalbiodefense.com
SUMMARY:Homeland Security & Governmental Affairs Committee: Protecting the U.S. from Global Pandemics
DESCRIPTION:The U.S. Senate Committee on Homeland Security & Governemental Affairs will convene a Full Committee hearing on Feb.12 to examine protecting the United States from global pandemics. \nROUNDTABLE: Are We Prepared? Protecting the U.S. from Global Pandemics will\nFebruary 12\, 2020 09:30 AM \nLocation: SD-G50\, Dirksen Senate Office Building \nThe meeting will air on CSPAN. \nSee also: Johnson\, Peters Ask DHS for Strategy for Containing the Coronavirus
URL:https://globalbiodefense.com/event/homeland-security-governmental-affairs-committee-protecting-the-u-s-from-global-pandemics/
LOCATION:Dirksen Senate Office Building\, Washington\, DC\, United States
CATEGORIES:Government Hosted,Policy-Legislative
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200211
DTEND;VALUE=DATE:20200213
DTSTAMP:20200209T193131Z
CREATED:20200209T192624Z
LAST-MODIFIED:20200209T193131Z
UID:39221-1581379200-1581551999@globalbiodefense.com
SUMMARY:WHO Global Research and Innovation Forum: 2019-nCoV Emergency
DESCRIPTION:The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. \nThe event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)\, and brings together key players including leading scientists as well as public health agencies\, ministries of health and research funders pursuing 2019-nCoV critical research and the development of vaccines\, therapeutics and diagnostics\, among other innovations. \nThe WHO R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of\nR&D activities during epidemics. Its aim is to fast-track the availability of effective tests\, vaccines and\nmedicines that can be used to save lives and avert large scale crisis. \nThe global imperative for research is to maintain a high-level discussion platform which enables\nconsensus on strategic directions\, nurtures scientific collaborations and\, supports optimal and rapid\nresearch to address crucial gaps\, without duplication of efforts. \nUnderstanding the disease\, its reservoirs\, its transmission\, its clinical severity and developing effective\ncounter measures is critical for the control of the outbreak\, the reduction of related mortality and\nminimization of economic impact. \nPurpose\nTo enable identification of key knowledge gaps\, and research priorities and thereby accelerate the\ngeneration of critical scientific information and the most needed medical products to contribute to\nthe control the 2019-nCoV emergency. \nExpected outcome\nA research roadmap with clearly defined priorities and governance framework addressing each of\nseveral thematic areas will be considered at the meeting\, namely: virus\, diagnostics; natural history\nand transmission; clinical; therapeutics; vaccines; ethics; regulatory science; animal health;\ndata/samples analysis and sharing and; social sciences. \nAttendees\nThe participants will include diverse multi-disciplinary teams:\n• Member States representatives from countries with cases\n• Representatives from the scientific community and public health agencies\n• Regulatory experts\n• Bioethicists with expertise in emergencies\n• Major funders of research\nWHO is delighted to welcome y
URL:https://globalbiodefense.com/event/who-global-research-and-innovation-forum-2019-ncov-emergency/
LOCATION:WHO Headquarters\, Geneva\, Switzerland
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200210T150000
DTEND;TZID=America/Los_Angeles:20200210T170000
DTSTAMP:20200203T162654Z
CREATED:20200203T162525Z
LAST-MODIFIED:20200203T162654Z
UID:38426-1581346800-1581354000@globalbiodefense.com
SUMMARY:The Novel Coronavirus: What Do We Know and What's Next?
DESCRIPTION:The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What’s Next?\, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan\, China in December 2019. On January 30\, 2020\, the WHO declared the outbreak a public health emergency of international concern. To address what we know and what’s next\, join Ron Brookmeyer\, dean of the UCLA Fielding School of Public Health\, and Michael Berry\, director of the UCLA Center for Chinese Studies\, in conversation with: \n\nRoger Detels\, professor\, UCLA Fielding School of Public Health\nAnne Rimoin\, professor\, UCLA Fielding School of Public Health\nAlex Wang\, professor\, UCLA School of Law\nOtto Yang\, professor\, Geffen School of Medicine at UCLA\nZuo-Feng Zhang\, professor\, UCLA Fielding School of Public Health\n\nFor more information\, including how to join the symposium via livestream\, please visit \nhttps://ph.ucla.edu/events/novel-coronavirus-what-do-we-know-and-whats-next
URL:https://globalbiodefense.com/event/the-novel-coronavirus-what-do-we-know-and-whats-next/
LOCATION:Neuroscience Research Building (NRB)\, 635 Charles E Young Drive South\, Los Angeles\, CA\, 90095\, United States
CATEGORIES:Conference
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/02/f34d7fcec7626144b08868be30aa3139-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T140000
DTEND;TZID=America/New_York:20200210T150000
DTSTAMP:20200126T190837Z
CREATED:20200126T190718Z
LAST-MODIFIED:20200126T190837Z
UID:37779-1581343200-1581346800@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-3/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200210T133000
DTEND;TZID=America/New_York:20200210T153000
DTSTAMP:20200203T162053Z
CREATED:20200203T161203Z
LAST-MODIFIED:20200203T162053Z
UID:38397-1581341400-1581348600@globalbiodefense.com
SUMMARY:Containing the Coronavirus: Challenges to Thwarting the Outbreak
DESCRIPTION:Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. \nConfirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic\, with thousands more suspected cases. As the number of cases increases\, concerns are mounting that the global community may not be adequately prepared to prevent the disease from significantly spreading. \nThe virus has already spread to more than 20 countries\, including the United States\, with at least six confirmed cases and more than 100 suspected across 36 states. The Center for Disease Control (CDC) is screening passengers arriving from China at several airports\, but much remains unknown about transmission and symptoms\, and a CDC-developed diagnostic test has yet to be distributed across the country. \nPanel participants will offer their perspectives on the role of the federal government in managing the crisis\, the lack of transparency by the Communist Chinese Government\, implications for U.S national security\, and how the country can better prepare for when the next pandemic strikes. \nThe event will feature U.S. Senator Joe Lieberman\, co-chair of the Bipartisan Commission on Biodefense\, scholars from Hudson Institute\, and other subject matter experts. \nNOTE: This event is open to the press. All members of the media should RSVP to press@hudson.org.
URL:https://globalbiodefense.com/event/containing-the-coronavirus-challenges-to-thwarting-the-outbreak/
LOCATION:Hudson Institute\, 1201 Pennsylvania Avenue Northwest\, #400\, Washington\, DC\, 20004\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200206T173000
DTEND;TZID=America/New_York:20200206T190000
DTSTAMP:20200206T190217Z
CREATED:20200203T163455Z
LAST-MODIFIED:20200206T190217Z
UID:38437-1581010200-1581015600@globalbiodefense.com
SUMMARY:Yale Forum on Outbreak of Novel Coronavirus
DESCRIPTION:In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China\, the Yale Institute for Global Health\, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday\, February 6\, 2020. Panelists will address the epidemiology of the disease\, its impact on public health\, human rights issues and how information on such outbreaks is communicated to the public.\n\nModerator \nSaad Omer\, Director\, Yale Institute for Global Health; Professor of Medicine (Infectious Diseases)\, Yale School of Medicine; Susan Dwight Bliss Professor of Epidemiology of Microbial Diseases\, Yale School of Public Health \nPanelists \nEllen Foxman\, Assistant Professor of Laboratory Medicine and Immunobiology\, Yale School of Medicine \nGregg Gonsalves\, Assistant Professor of Epidemiology; Associate (Adjunct) Professor of Law\, Yale Law School; Co-Director\, Global Health Justice Partnership \nNathan Grubaugh\, Assistant Professor of Epidemiology (Microbial Diseases)\, Yale School of Public Health \nLisa Sanders\, Associate Professor of Medicine (General Medicine)\, Yale School of Medicine; Emmy-award winning television producer\, author of The New York Times column Diagnosis \nDavid Vlahov\, Professor\, PhD Program Director\, Yale School of Nursing \nLive Stream Link \nhttps://yale.hosted.panopto.com/Panopto/Pages/Viewer.aspx?id=50702300-d8eb-4398-9d9e-ab530102bbbe
URL:https://globalbiodefense.com/event/yale-forum-on-outbreak-of-novel-coronavirus/
LOCATION:Winslow Auditorium\, 60 College Street\, LEPH 109\, New Haven\, CT\, 06510\, United States
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T140000
DTEND;TZID=America/New_York:20200203T150000
DTSTAMP:20200126T190909Z
CREATED:20200126T190529Z
LAST-MODIFIED:20200126T190909Z
UID:37776-1580738400-1580742000@globalbiodefense.com
SUMMARY:CDC National Call Series on Novel Coronavirus Monitoring & Preparedness
DESCRIPTION:The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City\, Hubei Province\, China. A number of countries\, including the U.S.\, are actively screening incoming travelers from Wuhan. \nStarting January 21\, 2020\, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national calls to continue providing state and local partners with the latest information on the novel coronavirus outbreak and U.S. preparedness efforts. \nThe call schedule is currently set as follows: \n\n21 January 2:00-3:00pm EST\n27 January 2:00-3:00pm EST\n3 February 2:00-3:00pm EST\n10 February 2:00-3:00pm EST\n24 February 2:00-3:00pm EST\n2 March 2:00-3:00pm EST\n\n  \nParticipant Information \nBridgeline: \n1(800)-857-6697 Participant \nPasscode: 1324420 \nIf you have any questions about the call series\, please contact the CDC State Coordination Task Force (SCTF) – Operations. \nh/t NACCHO for originally posting this information.
URL:https://globalbiodefense.com/event/cdc-national-call-series-on-novel-coronavirus-monitoring-preparedness-2/
CATEGORIES:Government Hosted,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200203T083000
DTEND;TZID=America/New_York:20200203T170000
DTSTAMP:20200115T031436Z
CREATED:20191115T030617Z
LAST-MODIFIED:20200115T031436Z
UID:37038-1580718600-1580749200@globalbiodefense.com
SUMMARY:Advancing EUA IVD Products Toward Full Marketing Status
DESCRIPTION:The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. \nA roadmap for diagnostic evaluations during emergencies would help enable stakeholders to have templates to use to expedite evaluation of laboratory-based tests and point of care technologies. By convening a broad range of government and industry stakeholders\, the goal of the workshop is: \nTo identify challenges and next steps to the use of RWD/RWE to help support the advancement of EUA IVD products to full marketing status. \nThe projected outcomes of the workshop include: \n\nIdentify test case(s) of interest to stakeholders\nDiscussion to inform development of a roadmap for diagnostic evaluations during emergencies\, to include what elements to collect (and how)\nIdentify potential projects or next steps for the test case(s) of interest\n\nKeynote Speakers: \n\nLuciana Borio\, MD; Vice President\, Technical Staff | In-Q-Tel\nNira Pollock\, MD\, PhD; Assoc Medical Director of Infectious Diseases Diagnostic Laboratory at Boston Children’s Hospital\, faculty member of the Division of Infectious Diseases at Beth Israel Deaconess Medical Center\, Boston\, MA.\n\nFDA Speakers: \n\nRADM Denise Hinton\, FDA Chief Scientist\nTimothy Stenzel\, MD\, PhD\, Director\, OHT7: Office of In Vitro Diagnostics and Radiological Health | CDRH\nUwe Scherf\, M.Sc.\, PhD\, Director\, Division of Microbiology Devices\, OHT7: Office of In Vitro Diagnostics and Radiological Health | CDRH
URL:https://globalbiodefense.com/event/advancing-eua-ivd-products-toward-full-marketing-status/
LOCATION:FDA White Oak Campus\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
CATEGORIES:Conference,Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200131T140000
DTEND;TZID=America/New_York:20200131T150000
DTSTAMP:20200131T163844Z
CREATED:20200131T143313Z
LAST-MODIFIED:20200131T163844Z
UID:37932-1580479200-1580482800@globalbiodefense.com
SUMMARY:CDC COCA Call: Outbreak of 2019-nCoV: Interim Guidance for Clinicians
DESCRIPTION:The CDC will hold a COCA (Clinicians Outreach and Communication Activity) call this afternoon with their latest recommendations. \n\nDue to the high demand we anticipate for this COCA Call\, we kindly ask participants to access it in a group format\, if at all possible\, to allow for the maximum number of participants to attend. \nTarget audience: \n\nPhysicians\nNurses\nPharmacists\nVeterinarians\nPhysician Assistants\nHealth Educators\nOther Clinicians\n\nPlease note\, there will be only a few introductory slides for this presentation. The subject matter covered during this webinar will not have an accompanying slide deck. \n\nContact Information:coca@cdc.gov\nSupport/Funding:Centers for Disease Control and Prevention\, Emergency Risk Communication Branch\n\nPRESENTERS \nAron Hall\, DVM\, MSPH\n2019-nCoV Epidemiology Task Force Deputy Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nWill Weldon\, PhD\n2019-nCoV Laboratory Task Force Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nTimothy Uyeki\, MD\, MPH\, MPP\n2019-nCoV Response Clinical Team Lead\nNational Center for Immunization and Respiratory Diseases\nCenters for Disease Control and Prevention \nRyan Fagan\, MD\, MPH&TM\n2019-nCoV Healthcare Infection Control Team Lead\nNational Center for Emerging and Zoonotic Infectious Diseases\nCenters for Disease Control and Prevention \nPlease visit the website for call-in information
URL:https://globalbiodefense.com/event/cdc-coca-call-outbreak-of-2019-ncov-interim-guidance-for-clinicians/
CATEGORIES:Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200131
DTEND;VALUE=DATE:20200201
DTSTAMP:20200116T175238Z
CREATED:20200116T173601Z
LAST-MODIFIED:20200116T175238Z
UID:37406-1580428800-1580515199@globalbiodefense.com
SUMMARY:Registration Deadline: MCMs for Acute and Chronic Effects of Ocular Chemical Toxicity
DESCRIPTION:Meeting registration will close on January 31\, 2020 for the U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity. \nThe meeting will be held Feb 25-26\, 2020 at the NIAID Conference Center in Rockville\, Md. \nThe meeting is sponsored by the Chemical Countermeasures Research Program (CCRP)\, a component of the broader civilian biodefense research effort within HHS and NIH. \nLearn More
URL:https://globalbiodefense.com/event/registration-deadline-mcms-for-acute-and-chronic-effects-of-ocular-chemical-toxicity/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
END:VCALENDAR